GSK
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
1.01K920.28752.86751.34
Price/Sales ratio
240.31227.13217.16216.02
Earnings per Share (EPS)
Β£1.58Β£1.74Β£2.13Β£2.13

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
19.396.3667.2634.0816.3415.309.3811.8511.7611.9221.8116.34
Price/Sales ratio
2.322.242.191.721.922.101.581.521.971.931.742.10
Price/Book Value ratio
12.5410.4854.57-767.8513.585.933.693.455.464.403.915.93
Price/Cash Flow ratio
10.3220.869.447.547.038.866.396.537.818.687.907.03
Price/Free Cash Flow ratio
15.6080.2314.7911.078.9312.148.7010.3511.2413.2812.698.93
Price/Earnings Growth ratio
-0.390.03-0.750.540.120.560.40-2.43-1.07N/A639.860.12
Dividend Yield
7.18%7.22%7.90%7.48%6.63%5.55%7.37%7.69%5.99%3.82%4.54%5.55%
Profitability Indicator Ratios
Gross Profit Margin
68.16%62.99%66.68%65.73%66.77%64.85%65.67%65.98%67.41%71.75%72.04%66.77%
Operating Profit Margin
15.63%43.14%9.31%13.53%17.78%20.62%22.82%18.17%21.93%22.24%16.63%20.62%
Pretax Profit Margin
12.90%43.99%6.95%11.67%15.57%18.43%20.43%15.95%19.19%19.99%10.52%18.43%
Net Profit Margin
11.97%35.20%3.27%5.07%11.75%13.76%16.85%12.85%16.78%16.24%8.01%13.76%
Effective Tax Rate
4.61%20.46%45.22%38.46%15.70%15.31%8.32%6.35%12.56%12.46%13.50%15.31%
Return on Assets
6.77%15.75%1.54%2.71%6.23%5.82%7.14%5.54%8.18%8.35%4.32%5.82%
Return On Equity
64.64%164.68%81.13%-2252.94%83.09%38.76%39.41%29.12%46.43%36.92%18.07%38.76%
Return on Capital Employed
13.14%25.78%6.48%13.70%15.41%12.51%13.35%11.18%17.23%17.77%14.23%14.23%
Liquidity Ratios
Current Ratio
1.101.230.870.590.750.810.91N/AN/AN/A0.800.75
Quick Ratio
0.780.880.610.380.500.560.640.540.680.620.530.50
Cash ratio
0.320.430.250.140.170.190.280.180.160.130.140.19
Days of Sales Outstanding
71.1783.7360.3956.4974.8659.3359.3966.8267.8671.06N/A59.33
Days of Inventory outstanding
210.88194.43200.45196.12195.17182.97186.99181.91196.59234.29246.78195.17
Operating Cycle
282.05278.16260.85252.61270.03242.31246.38248.74264.45305.36246.78242.31
Days of Payables Outstanding
139.06128.63141.28124.51129.91127.50135.87142.65147.69158.40599.43129.91
Cash Conversion Cycle
142.99149.53119.56128.10140.12114.80110.51106.08116.76146.96-352.65114.80
Debt Ratios
Debt Ratio
0.450.300.310.300.440.360.320.290.330.280.270.36
Debt Equity Ratio
4.383.2316.66-250.335.962.441.781.531.881.251.142.44
Long-term Debt to Capitalization
0.780.740.921.000.820.650.600.560.600.510.480.65
Total Debt to Capitalization
0.810.760.941.000.850.700.640.600.650.550.530.70
Interest Coverage Ratio
6.123.578.408.239.167.109.09N/AN/AN/A7.257.10
Cash Flow to Debt Ratio
0.270.150.340.400.320.270.320.340.370.400.430.32
Company Equity Multiplier
9.5310.4552.56-829.1313.316.645.515.255.674.424.146.64
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.220.100.230.220.270.230.240.230.250.220.220.23
Free Cash Flow / Operating Cash Flow Ratio
0.660.260.630.680.780.730.730.630.690.650.620.73
Cash Flow Coverage Ratio
0.270.150.340.400.320.270.320.340.370.400.430.32
Short Term Coverage Ratio
1.771.991.582.461.451.202.412.341.952.542.461.45
Dividend Payout Ratio
139.44%45.99%531.79%254.96%108.39%85.10%69.17%91.19%70.45%45.59%95.57%95.57%